Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NervGen Pharma today announced that the Company will ring the closing bell at the Nasdaq Stock Market on Thursday, January 22, 2026 in New York City
-
NervGen Pharma's common shares have been approved for listing on Nasdaq and will begin trading today, under the symbol "NGEN"
-
UNITED KINGDOM, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Energys Group Limited (NASDAQ: ENGS) (“Energys Group” or the “Company”), a vertically integrated energy efficiency and decarbonization solutions...
-
Dreamland Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Jericho, New York, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering and...
-
Dreamland Limited Announces Closing of Initial Public Offering
-
Dreamland Limited Announces Pricing of Initial Public Offering
-
New York, NY, July 09, 2025 (GLOBE NEWSWIRE) -- AlphaTime Acquisition Corp (Nasdaq: ATMC, ATMCU, ATMCR, ATMCW) (“AlphaTime” or the “Company”), a special purpose acquisition company, today announced...
-
KUALA LUMPUR, Malaysia, April 01, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), a diversified holding company with expertise in consulting, fintech, AI,...
-
Los Angeles, CA, March 26, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company"), a medical technology company delivering unprecedented accuracy and precision to...